Krebs Biochemicals & Industr Balance Sheet Annual

Trade

BSE: 524518 | NSE: KREBSBIO | ISIN: INE268B01013 | Sector: Biotechnology & Drugs

98.53 +15.81 (19.11%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	0.14	0.00	0.00	0.00
Short Term Investments	3.01	0.00	-	-
Cashand Short Term Investments	3.15	0.02	0.03	0.59
Accounts Receivable- Trade Net	1.90	0.65	0.88	0.30
Total Receivables Net	1.90	3.10	9.03	3.41
Total Inventory	9.80	12.36	25.86	16.89
Other Current Assets Total	2.59	0.07	0.07	0.13
Total Current Assets	17.44	16.06	35.49	21.42
Property/ Plant/ Equipment Total- Net	149.46	148.71	144.22	126.35
Intangibles Net	2.50	2.69	2.87	3.51
Long Term Investments	2.54	-	0.00	0.00
Other Long Term Assets Total	6.23	2.71	2.63	2.58
Total Assets	178.17	174.98	189.81	159.22
Accounts Payable	18.97	15.28	37.91	20.78
Accrued Expenses	0.44	2.74	1.17	1.49
Notes Payable/ Short Term Debt	9.93	9.99	9.99	0.00
Other Currentliabilities Total	32.49	20.96	28.82	25.33
Total Current Liabilities	61.83	49.10	78.06	48.19
Long Term Debt	183.50	173.25	132.93	100.55
Total Long Term Debt	183.50	173.25	132.93	100.55
Total Debt	193.43	183.37	143.10	101.14
Other Liabilities Total	52.06	52.09	53.90	53.21
Total Liabilities	297.39	274.44	264.90	201.95
Common Stock Total	21.56	21.56	21.56	19.62
Retained Earnings( Accumulated Deficit)	-140.78	-250.49	-226.12	-181.24
Total Equity	-119.22	-99.46	-75.09	-42.73
Total Liabilities Shareholders' Equity	178.17	174.98	189.81	159.22
Total Common Shares Outstanding	2.16	2.16	2.16	1.96
Tangible Book Valueper Share Common Eq	-56.45	-47.38	-36.16	-23.57
Cash	-	0.02	0.03	0.59
Prepaid Expenses	-	0.52	0.49	0.40
Property/ Plant/ Equipment Total- Gross	-	302.46	291.66	268.14
Accumulated Depreciation Total	-	-153.75	-147.45	-141.79
Note Receivable- Long Term	-	4.81	4.59	5.36
Current Portof LT Debt/ Capital Leases	-	0.13	0.18	0.59
Additional Paid- In Capital	-	118.02	118.02	107.44
Other Equity Total	-	11.44	11.44	11.44